| Dr Kia C Pratt Mccoy, MD | |
|
175 Madison Ave, Mount Holly, NJ 08060-2038 | |
| (609) 914-6180 | |
| (609) 914-6182 |
| Full Name | Dr Kia C Pratt Mccoy |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 175 Madison Ave, Mount Holly, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508892480 | NPI | - | NPPES |
| 2710668007 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Southern Maryland Hospital Center | Clinton, MD | Hospital |
| Mary Washington Hospital | Fredericksburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Washington Medical Group Hospitalist Services, Llc | 1456629369 | 75 |
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Today's headlines reflect news about health reform implementation activities, health information technology and sparring opinions about the Massachusetts experience.
Out of chaos, control: Cornell University molecular biologists have discovered how a protein called PARP-1 binds to genes and regulates their expression across the human genome.
Older adults are understandably anxious about the political sniping over the future financing of Medicare. That is precisely the intention of the presidential campaigns. Yet the cross-fire over who will cut Medicare by how much sidesteps a critical issue about the future of our medical care: If we must ration our care to hold down costs in the future, how can we do it in a fair, efficient and transparent way?
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20080806000696 |
News Archive
Today's headlines reflect news about health reform implementation activities, health information technology and sparring opinions about the Massachusetts experience.
Out of chaos, control: Cornell University molecular biologists have discovered how a protein called PARP-1 binds to genes and regulates their expression across the human genome.
Older adults are understandably anxious about the political sniping over the future financing of Medicare. That is precisely the intention of the presidential campaigns. Yet the cross-fire over who will cut Medicare by how much sidesteps a critical issue about the future of our medical care: If we must ration our care to hold down costs in the future, how can we do it in a fair, efficient and transparent way?
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Entity Name | Mary Washington Medical Group Hospitalist Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750826277 PECOS PAC ID: 1456629369 Enrollment ID: O20170619001149 |
News Archive
Today's headlines reflect news about health reform implementation activities, health information technology and sparring opinions about the Massachusetts experience.
Out of chaos, control: Cornell University molecular biologists have discovered how a protein called PARP-1 binds to genes and regulates their expression across the human genome.
Older adults are understandably anxious about the political sniping over the future financing of Medicare. That is precisely the intention of the presidential campaigns. Yet the cross-fire over who will cut Medicare by how much sidesteps a critical issue about the future of our medical care: If we must ration our care to hold down costs in the future, how can we do it in a fair, efficient and transparent way?
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kia C Pratt Mccoy, MD 401 Route 73 N, 40 Lake Center Dr Suite 201a, Marlton, NJ 08053-3425 Ph: (856) 355-0340 | Dr Kia C Pratt Mccoy, MD 175 Madison Ave, Mount Holly, NJ 08060-2038 Ph: (609) 914-6180 |
News Archive
Today's headlines reflect news about health reform implementation activities, health information technology and sparring opinions about the Massachusetts experience.
Out of chaos, control: Cornell University molecular biologists have discovered how a protein called PARP-1 binds to genes and regulates their expression across the human genome.
Older adults are understandably anxious about the political sniping over the future financing of Medicare. That is precisely the intention of the presidential campaigns. Yet the cross-fire over who will cut Medicare by how much sidesteps a critical issue about the future of our medical care: If we must ration our care to hold down costs in the future, how can we do it in a fair, efficient and transparent way?
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
Dr. Jubril Oyekanmi Oyeyemi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Erik Delue, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Zaheer Husain, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Pierre Rigens Valeus, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-267-0700 | |
Dr. Swati Hasmukh Patel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Hospitalist Group, Mount Holly, NJ 08060 Phone: 609-267-0700 | |
Dr. James Ward, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 Fax: 609-914-6182 | |
Brian Peng, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 |